Search in:

Vascular Health and Risk Management Volume 14, 2018 - Issue

Submit an article Journal homepage

Open access

324

Views

CrossRef citations to date

Altmetric

Review

Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice

Kavitha Vimalesvaran1 Department of Cardiology, East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, UKCorrespondence[email protected]

Seth J Dockrill1 Department of Cardiology, East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, UK

Diana A Gorog1 Department of Cardiology, East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, UK;2 School of Life and Medical Sciences, Postgraduate Medical School, University of Hertfordshire, Hertfordshire, UK;3 Faculty of Medicine, National Heart and Lung Institute, Imperial College, London, UK

Pages 13-21 | Published online: 09 Jan 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

Yaoyao Ding, Hui Jiang, Jingzhe Liu, Dexin Chen & Fuguo Yang. (2023) Effects of the theory of planned behavior and nudge strategy-based intervention on the adherence to anticoagulation treatment in patients with non-valvular atrial fibrillation. Geriatric Nursing 51, pages 17-24.
Crossref

K.I. Bentsionova, Z.I. Rossokha, O.G. Ievseienkova & N.G. Gorovenko. (2023) Pharmacogenetic substantiation of personalized prescription of oral anticoagulants in clinical practice. Medicni perspektivi 28:1, pages 55-68.
Crossref

Maya Said Al-Maawali, Hamed Hilal Al-Naamani, Leila Neshat Mokadem, Ghalib Al-Maawali, Bushra Salman & Ibrahim Al-Zakwani. (2022) Comparative Effectiveness and Safety of Rivaroxaban and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in an Omani Tertiary Care Hospital. The Open Cardiovascular Medicine Journal 16:1.
Crossref

Svetlana Apostolović, Dragana Stanojević & Tomislav Kostić. (2022) New oral anticoagulants in nonvalvular atrial fibrillation. Galenika Medical Journal 1:1, pages 22-27.
Crossref

. 2022. Genesis, Pathophysiology and Management of Venous and Lymphatic Disorders. Genesis, Pathophysiology and Management of Venous and Lymphatic Disorders 461 481 .

Ayesha Javed, Muhammad Ajmal & Aaron Wolfson. (2021) Dabigatran in cardiovascular disease management: A comprehensive review. World Journal of Cardiology 13:12, pages 710-719.
Crossref

Meghdad Sedaghat, Behnam Safarpour Lima, Reihanesadat Bouzari & Sarvenaz Shadlou. (2021) Gastrointestinal Bleeding Associated With Warfarin and Rivaroxaban Therapy in Atrial Fibrillation Cases with Concomitant Coagulopathy. Cardiovascular & Hematological Disorders-Drug Targets 21:2, pages 123-127.
Crossref

Muhammad Ajmal, Jacob Friedman, Qurat Ul Ain Riaz Sipra & Tom Lassar. (2021) Rivaroxaban: Expanded Role in Cardiovascular Disease Management—A Literature Review. Cardiovascular Therapeutics 2021, pages 1-9.
Crossref

A. D. Erlikh. (2020) Atrial fibrillation in elderly patients. Features of using rivaroxaban. Atherothrombosis:1, pages 9-16.
Crossref

Faisal Imam, Naif Obaid Al-Harbi, Mohammad Rashid Khan, Wajhul Qamar, Metab Alharbi, Ali A. Alshamrani, Hussain N. Alhamami, Nasser Bader Alsaleh & Khalid Saad Alharbi. (2019) Protective Effect of RIVA Against Sunitinib-Induced Cardiotoxicity by Inhibiting Oxidative Stress-Mediated Inflammation: Probable Role of TGF-β and Smad Signaling. Cardiovascular Toxicology 20:3, pages 281-290.
Crossref

Radica Stepanović-Petrović & Katarina Nastić. (2020) Direct oral anticoagulants: A new chapter in anticoagulation therapy. Arhiv za farmaciju 70:5, pages 249-268.
Crossref

Luca Di Lullo, Claudio Ronco, Fulvio Floccari, Antonio De Pascalis, Vincenzo Barbera, Rodolfo Rivera & Antonio Bellasi. (2019) Rivaroxaban e malattia renale cronica: evidenze dal presente e prospettive future. Giornale di Tecniche Nefrologiche e Dialitiche 31:1, pages 30-36.
Crossref

Sri H. Kanuri & Rolf P. Kreutz. (2019) Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants. Journal of Personalized Medicine 9:1, pages 7.
Crossref

Luca Di Lullo, Giovanni Tripepi, Claudio Ronco, Antonio De Pascalis, Vincenzo Barbera, Antonio Granata, Domenico Russo, Biagio Raffaele Di Iorio, Ernesto Paoletti, Maura Ravera, Maria Fusaro & Antonio Bellasi. (2018) Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data. Journal of Nephrology 31:5, pages 751-756.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice

Citations (14)

Articles from other publishers (14)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date